152 Episoder

  1. 2023 Health Trends: Personally, Purposefully Building What’s Next

    Publisert: 29.11.2022
  2. Real World Evidence and Rare Diseases, Part 3: The Value of Registries

    Publisert: 3.11.2022
  3. Decentralized Clinical Trials: Implications for Biotech

    Publisert: 5.10.2022
  4. Full-Service Commercial

    Publisert: 21.9.2022
  5. MAPS Edition: Value Demonstration - A View From the Top

    Publisert: 8.8.2022
  6. MAPS Edition: Bringing Medical Affairs Into the C-Suite

    Publisert: 8.8.2022
  7. Opportunities and Challenges in Cell and Gene Therapy

    Publisert: 14.7.2022
  8. MAPS Edition: Recruiting for the New Profile of Medical Affairs

    Publisert: 1.7.2022
  9. MAPS Edition: Stakeholder Engagement in a Data-Driven Environment

    Publisert: 27.6.2022
  10. MAPS Edition: Measuring the Immeasurable: Value and Impact of Medical Affairs

    Publisert: 8.6.2022
  11. MAPS Edition: Be Bold - Preparing Medical Affairs for 2030 and Beyond

    Publisert: 20.5.2022
  12. Training the Next Generation of Pharma

    Publisert: 13.5.2022
  13. Getting Access

    Publisert: 27.4.2022
  14. Epilepsy, the Central Nervous System and Rare Disease

    Publisert: 13.4.2022
  15. The Placebo Effect

    Publisert: 23.3.2022
  16. Mental Health in Rare Disease

    Publisert: 9.2.2022
  17. Navigating the Rare Disease Landscape

    Publisert: 2.2.2022
  18. Business Continuity Through Strategic Outsourcing

    Publisert: 5.1.2022
  19. The Virtual Sales Organization

    Publisert: 3.11.2021
  20. Thirty Years of Physician Answers

    Publisert: 16.9.2021

3 / 8

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.

Visit the podcast's native language site